Sarah Furlong

ORCID: 0000-0001-5914-500X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Amyotrophic Lateral Sclerosis Research
  • Neurological diseases and metabolism
  • Neurogenetic and Muscular Disorders Research
  • Epigenetics and DNA Methylation
  • Cancer-related gene regulation
  • Parkinson's Disease Mechanisms and Treatments
  • Cholinesterase and Neurodegenerative Diseases
  • Alzheimer's disease research and treatments
  • Autism Spectrum Disorder Research
  • Genetic Associations and Epidemiology
  • Genetics and Neurodevelopmental Disorders

Macquarie University
2020-2022

Illumina (United States)
2021

King's College London
2021

Neuroscience Institute
2021

The University of Queensland
2017

By employing chip-based capillary zone electrophoresis coupled to high-resolution mass spectrometry, we profiled the plasma metabolome of 134 patients diagnosed with sporadic amyotrophic lateral sclerosis (ALS) (81 males and 53 females) 118 individuals deemed healthy (49 69 females). The most significant markers (p < 0.01) were creatine, which was 49% elevated, creatinine methylhistidine, decreased by 20 24%, respectively, in ALS patients. ratio creatine versus increased 370 200% for male...

10.1021/acs.jproteome.0c00216 article EN Journal of Proteome Research 2020-05-18

Abstract Background Gene discovery has provided remarkable biological insights into amyotrophic lateral sclerosis ( ALS ). One challenge for clinical application of genetic testing is critical evaluation the significance reported variants. Methods We use whole exome sequencing WES ) to develop a clinically relevant approach identify subset patients harboring likely pathogenic mutations. In parallel, we assess if DNA methylation can be used screen pathogenicity novel variants since signature...

10.1002/mgg3.302 article EN cc-by Molecular Genetics & Genomic Medicine 2017-06-12

Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an estimated heritability of around 50%. DNA methylation patterns can serve as biomarkers (past) exposures and progression, well providing potential mechanism that mediates genetic or environmental risk. Here, we present blood-based epigenome-wide association study (EWAS) meta-analysis in 10,462 samples (7,344 ALS patients 3,118 controls), representing the largest case-control for any to date. We...

10.1101/2021.03.12.21253115 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-03-24
Coming Soon ...